医療用特殊酵素の世界市場：機会・戦略（～2031年）

当レポートでは、世界の医療用特殊酵素市場について調査し、タイプ・由来・用途別セグメンテーション、主要市場動向、市場規模と成長、地域・国別分析、企業プロファイル等に関する情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図一覧

第4章 表一覧

第5章 レポートの構造

第6章 イントロダクションと市場の特徴

• 一般的な市場の定義
• 概要
• 医療用特殊酵素市場の定義とセグメンテーション
• 市場セグメンテーション：タイプ別
  • カルボヒドラーゼ
  • プロテアーゼ
  • リパーゼ
  • ポリメラーゼ・ヌクレアーゼ
  • オキシダーゼ・ヒドラターゼ
  • その他のタイプ
• 市場セグメンテーション：由来別
  • 微生物
  • 動物
  • 植物
• 市場セグメンテーション：用途別
  • 医薬品
  • 研究・バイオテクノロジー
  • 診断
  • 生体触媒

第7章 主要市場動向

• バイオテクノロジーセクターにおける技術進歩
• 研究・バイオテクノロジーセクターへの投資の増加
• 製品発売
• 酵素工学の進歩
• パートナーシップ、コラボレーション、契約
• 機械学習と人工知能の統合
• 酵素ベース診断バイオセンサーへのシフトの増加

第8章 世界の市場規模と成長

• 市場規模
• 市場成長の実績、2016年～2021年、金額（100万米ドル）
  • 市場促進要因、2016年～2021年
  • 市場抑制要因、2016年～2021年
• 市場成長の予測、2021年～2026年、2031年F、金額（100万米ドル）
  • 市場促進要因、2021年～2026年
  • 市場抑制要因、2021年～2026年

第9章 世界市場のセグメンテーション

• 世界の医療用特殊酵素市場、セグメンテーション：タイプ別、実績・予測、2016年～2021年、2026年F、2031年F、金額（100万米ドル）
• 世界の医療用特殊酵素市場、セグメンテーション：由来別、実績・予測、2016年～2021年、2026年F、2031年F、金額（100万米ドル）
• 世界の医療用特殊酵素市場、セグメンテーション：用途別、実績・予測、2016年～2021年、2026年F、2031年F、金額（100万米ドル）

第10章 世界市場、地域・国別分析

• 世界の医療用特殊酵素市場、地域別、実績・予測、2016年～2021年、2026年F、2031年F、金額（100万米ドル）
• 世界の医療用特殊酵素市場、国別、実績・予測、2016年～2021年、2026年F、2031年F、金額（100万米ドル）

第11章 アジア太平洋市場

第12章 西欧市場

第13章 東欧市場

第14章 北米市場

第15章 南米市場

第16章 中東市場

第17章 アフリカ市場

第18章 競合情勢と企業プロファイル

• 企業プロファイル
• F. Hoffmann-La Roche AG
• Merck Millipore
• Thermo Fisher Scientific, Inc (Affymetrix, Inc.)
• Codexis Inc.
• Sekisui Diagnostics
• Advanced Enzymes
• New England Biolabs
• Promega Corporation

第19章 主要な合併と買収

第20章 世界の医療用特殊酵素市場：機会・戦略

第21章 医療用特殊酵素市場：結論・提言

第22章 付録

“Healthcare Specialty Enzymes Global Market Opportunities And Strategies To 2031 ” from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global healthcare specialty enzymes market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.

• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

• Create regional and country strategies on the basis of local data and analysis.

• Identify growth segments for investment.

• Outperform competitors using forecast data and the drivers and trends shaping the market.

• Understand customers based on the latest market research findings.

• Benchmark performance against key competitors.

• Utilize the relationships between key data sets for superior strategizing.

• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Where is the largest and fastest growing market for healthcare specialty enzymes? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? “The healthcare specialty enzymes market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider healthcare specialty enzymes market; and compares it with other markets.

The report covers the following chapters:

• Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the healthcare specialty enzymes market.

• Key Trends - Highlights the major trends shaping the global healthcare specialty enzymes market. This section also highlights likely future developments in the market.

• Global Market Size and Growth - Global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

• Regional And Country Analysis - Historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region and country.

• Market Segmentation - Contains the market values (2016-2031) and analysis for for segment by type, by source, and by application in the market.

• Regional Market Size and Growth - Regional market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

• Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

• Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

• Market Opportunities And Strategies -Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

• Conclusions And Recommendations - Includes recommendations for healthcare specialty enzymes providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

• Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

• 1) By Type: Carbohydrases; Proteases; Lipases; Polymerases And Nucleases; Oxidase And Hydratases; Other Types

• 2) By Source: Microorganisms; Animals; Plants

• 3) By Application: Pharmaceuticals; Research And Biotechnology; Diagnostics; Biocatalysts

• Companies Mentioned: F. Hoffmann-La Roche AG; Merck Millipore; Thermo Fisher Scientific Inc. (Affymetrix, Inc.); Codexis, Inc.; Sekisui Diagnostics

• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; healthcare specialty enzymes indicators comparison.

• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction and Market Characteristics

• 6.1. General Market Definition
• 6.2. Summary
• 6.3. Healthcare Specialty Enzymes Market Definition and Segmentations
• 6.4. Market Segmentation By Type
  • 6.4.1. Carbohydrases
  • 6.4.2. Proteases
  • 6.4.3. Lipases
  • 6.4.4. Polymerases And Nucleases
  • 6.4.5. Oxidase And Hydratases
  • 6.4.6. Other Types
• 6.5. Market Segmentation By Source
  • 6.5.1. Microorganisms
  • 6.5.2. Animals
  • 6.5.3. Plants
• 6.6. Market Segmentation By Application
  • 6.6.1. Pharmaceuticals
  • 6.6.2. Research And Biotechnology
  • 6.6.3. Diagnostics
  • 6.6.4. Biocatalysts

7. Major Market Trends

• 7.1. Technological Advancements In Biotechnology Sector
• 7.2. Increasing Investments In Research And Biotechnology Sector
• 7.3. Product Launch
• 7.4. Advancement In Enzyme Engineering
• 7.5. Partnerships, Collaborations, and Agreements
• 7.6. Integration Of Machine Learning And Artificial Intelligence
• 7.7. Increasing Shift Towards Enzyme-Based Diagnostic Biosensors

8. Global Market Size And Growth

• 8.1. Market Size
• 8.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 8.2.1. Market Drivers 2016 - 2021
  • 8.2.2. Market Restraints 2016 - 2021
• 8.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 8.3.1. Market Drivers 2021 - 2026
  • 8.3.2. Market Restraints 2021 - 2026

9. Global Market Segmentation

• 9.1. Global Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 9.2. Global Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 9.3. Global Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

10. Global Market, Regional And Country Analysis

• 10.1. Global Healthcare Specialty Enzymes Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 10.2. Global Healthcare Specialty Enzymes Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

11. Asia-Pacific Market

• 11.1. Summary
• 11.2. Market Overview
  • 11.2.1. Region Information
  • 11.2.2. Market Information
  • 11.2.3. Background Information
  • 11.2.4. Government Initiatives
  • 11.2.5. Regulations
  • 11.2.6. Regulatory Bodies
  • 11.2.7. Major Associations
  • 11.2.8. Taxes Levied
  • 11.2.9. Corporate Tax Structure
  • 11.2.10. Investments
  • 11.2.11. Major Companies
• 11.3. Asia-Pacific Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.4. Asia-Pacific Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.5. Asia-Pacific Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.6. Asia-Pacific Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.7. Asia-Pacific Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.8. Asia Pacific Healthcare Specialty Enzymes Market: Country Analysis
• 11.9. China Market
• 11.10. Summary
• 11.11. Market Overview
  • 11.11.1. Country Information
  • 11.11.2. Market Information
  • 11.11.3. Background Information
  • 11.11.4. Government Initiatives
  • 11.11.5. Regulations
  • 11.11.6. Regulatory Bodies
  • 11.11.7. Major Associations
  • 11.11.8. Taxes Levied
  • 11.11.9. Corporate Tax Structure
  • 11.11.10. Investments
  • 11.11.11. Major Companies
• 11.12. China Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.13. China Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.14. China Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.15. China Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.16. India Market
• 11.17. India Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.18. India Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.19. India Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.20. India Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.21. Japan Market
• 11.22. Japan Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.23. Japan Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.24. Japan Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.25. Japan Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.26. Australia Market
• 11.27. Australia Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.28. Australia Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.29. Australia Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.30. Australia Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.31. Indonesia Market
• 11.32. Indonesia Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.33. Indonesia Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.34. Indonesia Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.35. Indonesia Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.36. South Korea Market
• 11.37. South Korea Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 11.38. South Korea Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 11.39. South Korea Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 11.40. South Korea Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Western Europe Market

• 12.1. Summary
• 12.2. Market Overview
  • 12.2.1. Region Information
  • 12.2.2. Market Information
  • 12.2.3. Background Information
  • 12.2.4. Government Initiatives
  • 12.2.5. Regulations
  • 12.2.6. Regulatory bodies
  • 12.2.7. Major Associations
  • 12.2.8. Taxes Levied
  • 12.2.9. Corporate Tax Structure
  • 12.2.10. Investments
  • 12.2.11. Major Companies
• 12.3. Western Europe Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 12.4. Western Europe Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 12.5. Western Europe Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.6. Western Europe Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.7. Western Europe Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.8. Western Europe Healthcare Specialty Enzymes Market: Country Analysis
• 12.9. UK Market
• 12.10. UK Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 12.11. UK Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 12.12. UK Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.13. UK Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.14. Germany Market
• 12.15. Germany Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 12.16. Germany Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 12.17. Germany Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.18. Germany Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.19. France Market
• 12.20. France Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 12.21. France Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 12.22. France Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 12.23. France Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Eastern Europe Market

• 13.1. Summary
• 13.2. Market Overview
  • 13.2.1. Region Information
  • 13.2.2. Market Information
  • 13.2.3. Background Information
  • 13.2.4. Government Initiatives
  • 13.2.5. Regulations
  • 13.2.6. Regulatory Bodies
  • 13.2.7. Major Associations
  • 13.2.8. Taxes Levied
  • 13.2.9. Corporate Tax Structure
  • 13.2.10. Investments
  • 13.2.11. Major Companies
• 13.3. Eastern Europe Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 13.4. Eastern Europe Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 13.5. Eastern Europe Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 13.6. Eastern Europe Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 13.7. Eastern Europe Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 13.8. Eastern Europe Healthcare Specialty Enzymes Market: Country Analysis
• 13.9. Russia Market
• 13.10. Russia Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 13.11. Russia Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 13.12. Russia Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 13.13. Russia Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. North America Market

• 14.1. Summary
• 14.2. Market Overview
  • 14.2.1. Region Information
  • 14.2.2. Market Information
  • 14.2.3. Background Information
  • 14.2.4. Government Initiatives
  • 14.2.5. Regulations
  • 14.2.6. Regulatory Bodies
  • 14.2.7. Major Associations
  • 14.2.8. Taxes levied
  • 14.2.9. Investments
  • 14.2.10. Major Companies
• 14.3. North America Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 14.4. North America Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 14.5. North America Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 14.6. North America Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 14.7. North America Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 14.8. North America Healthcare Specialty Enzymes Market: Country Analysis
• 14.9. USA Market
• 14.10. Summary
• 14.11. Market Overview
  • 14.11.1. Country Information
  • 14.11.2. Market Information
  • 14.11.3. Background Information
  • 14.11.4. Government Initiatives
  • 14.11.5. Regulations
  • 14.11.6. Regulatory bodies
  • 14.11.7. Major Associations
  • 14.11.8. Taxes levied
  • 14.11.9. Corporate tax structure
  • 14.11.10. Investments
  • 14.11.11. Major Companies
• 14.12. USA Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 14.13. USA Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 14.14. USA Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 14.15. USA Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. South America Market

• 15.1. Summary
• 15.2. Market Overview
  • 15.2.1. Region Information
  • 15.2.2. Market Information
  • 15.2.3. Background Information
  • 15.2.4. Government Initiatives
  • 15.2.5. Regulations
  • 15.2.6. Regulatory Bodies
  • 15.2.7. Major Associations
  • 15.2.8. Taxes Levied
  • 15.2.9. Corporate Tax Structure
  • 15.2.10. Investments
  • 15.2.11. Major Companies
• 15.3. South America Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 15.4. South America Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 15.5. South America Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 15.6. South America Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 15.7. South America Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 15.8. South America Healthcare Specialty Enzymes Market: Country Analysis
• 15.9. Brazil Market
• 15.10. Brazil Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 15.11. Brazil Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 15.12. Brazil Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 15.13. Brazil Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. Middle East Market

• 16.1. Summary
• 16.2. Market Overview
  • 16.2.1. Region Information
  • 16.2.2. Market Information
  • 16.2.3. Background Information
  • 16.2.4. Government Initiatives
  • 16.2.5. Regulations
  • 16.2.6. Regulatory Bodies
  • 16.2.7. Major Associations
  • 16.2.8. Taxes Levied
  • 16.2.9. Corporate Tax Structure
  • 16.2.10. Investments
  • 16.2.11. Major Companies
• 16.3. Middle East Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 16.4. Middle East Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 16.5. Middle East Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 16.6. Middle East Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 16.7. Middle East Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. Africa Market

• 17.1. Summary
• 17.2. Market Overview
  • 17.2.1. Region Information
  • 17.2.2. Market Information
  • 17.2.3. Background Information
  • 17.2.4. Government Initiatives
  • 17.2.5. Regulations
  • 17.2.6. Regulatory Bodies
  • 17.2.7. Major Associations
  • 17.2.8. Taxes Levied
  • 17.2.9. Corporate Tax Structure
  • 17.2.10. Investments
  • 17.2.11. Major Companies
• 17.3. Africa Healthcare Specialty Enzymes Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
• 17.4. Africa Healthcare Specialty Enzymes Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
• 17.5. Africa Healthcare Specialty Enzymes Market, Segmentation By Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 17.6. Africa Healthcare Specialty Enzymes Market, Segmentation By Source, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
• 17.7. Africa Healthcare Specialty Enzymes Market, Segmentation By Application, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Competitive Landscape And Company Profiles

• 18.1. Company Profiles
• 18.2. F. Hoffmann-La Roche AG
  • 18.2.1. Company Overview
  • 18.2.2. Products And Services
  • 18.2.3. Business Strategy
  • 18.2.4. Financial Overview
• 18.3. Merck Millipore
  • 18.3.1. Company Overview
  • 18.3.2. Products And Services
  • 18.3.3. Business Strategy
  • 18.3.4. Financial Overview
• 18.4. Thermo Fisher Scientific, Inc (Affymetrix, Inc.)
  • 18.4.1. Company Overview
  • 18.4.2. Products And Services.
  • 18.4.3. Business Strategy
  • 18.4.4. Financial Overview
• 18.5. Codexis Inc.
  • 18.5.1. Company Overview
  • 18.5.2. Products And Services
  • 18.5.3. Business Strategy
  • 18.5.4. Financial Overview
• 18.6. Sekisui Diagnostics
  • 18.6.1. Company Overview
  • 18.6.2. Products and Services
  • 18.6.3. Business Strategy
  • 18.6.4. Financial Overview
• 18.7. Advanced Enzymes
  • 18.7.1. Company Overview
  • 18.7.2. Products and Services
  • 18.7.3. Business Strategy
  • 18.7.4. Financial Overview
• 18.8. New England Biolabs
  • 18.8.1. Company Overview
  • 18.8.2. Products and Services
  • 18.8.3. Business Strategy
  • 18.8.4. Financial Overview
• 18.9. Promega Corporation
  • 18.9.1. Company Overview
  • 18.9.2. Products and Services
  • 18.9.3. Business Strategy
  • 18.9.4. Financial Overview

19. Key Mergers and Acquisitions

• 19.1. Kerry Acquired C-LEcta and Enmex
• 19.2. Roche Acquired TIB Molbiol
• 19.3. ADM Acquired Deerland Probiotics And Enzymes
• 19.4. Novozymes Acquired The Data Science Platform Of Biota
• 19.5. BRAIN Biotech AG Acquired Biocatalysts Ltd.
• 19.6. Advanced Enzyme Technologies Acquired SciTech Specialties
• 19.7. Advanced Enzyme Acquired Majority Stake In Scitech Specialties
• 19.8. Deerland Probiotics & Enzymes Acquired Bifodan A/S

20. Global Healthcare Specialty Enzymes Market Opportunities And Strategies

• 20.1. Global Healthcare Specialty Enzymes Market In 2026 - Countries Offering Most New Opportunities
• 20.2. Global Healthcare Specialty Enzymes Market In 2026 - Segments Offering Most New Opportunities
• 20.3. Global Healthcare Specialty Enzymes Market In 2026 - Growth Strategies
  • 20.3.1. Market Trend Based Strategies
  • 20.3.2. Competitor Strategies

21. Healthcare Specialty Enzymes Market, Conclusions And Recommendations

• 21.1. Conclusions
• 21.2. Recommendations
  • 21.2.1. Product
  • 21.2.2. Place
  • 21.2.3. Price
  • 21.2.4. Promotion
  • 21.2.5. People

22. Appendix

• 22.1. Market Data Sources
• 22.2. Research Methodology
• 22.3. Currencies
• 22.4. The Business Research Company
• 22.5. Copyright and Disclaimer